Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
8/29/2025
Eli Lilly Partners with JD Health for Popular Weight-Loss Medicines
8/29/2025
Fosun Secures Exclusive Rights to ACCRO’s AC-201 in Greater China
8/29/2025
Adcoris Raises CNY Tens of Millions to Advance Next-Gen ADC Programs
8/29/2025
MagicRNA Raises ~CNY 100M in Pre-A+ Financing to Advance HN2301 Thera...
8/27/2025
China Pushes for Biopharma-Focused Investment Funds to Accelerate Sect...
8/27/2025
Royalty Pharma Targets China's Biotech Market with Early-Stage Investm...
8/27/2025
CRO ChemPartner to Open New Boston Research Hub in September
8/27/2025
Tibet Rhodiola Bets Big on Cutting-Edge Gene-Editing Pioneer AccurEdit...
8/26/2025
InxMed Advances in Oncology with Upcoming IPO and Promising Pipeline
8/26/2025
Fosun and Sitala Forge Strategic Global Partnership for FXS6837
8/25/2025
Minova Secures Over ¥100M in Series B Financing Led by IDG Capital
8/25/2025
Vibrant Secures Series A Financing to Advance Computational I/O Therap...
8/25/2025
BeOne Nets Up to $950M in Royalty Deal for Amgen’s Lung Cancer Drug
8/25/2025
Anye Pharma Completes Series A Financing to Advance Neurological Drug ...
8/23/2025
IxCell Secures New Financing to Advance Cell Therapy Programs
8/22/2025
InxMed Secures Over $34M in Series C Financing to Advance Oncology Pip...
8/22/2025
Bao Pharma Advances with Hong Kong IPO amid Promising Pipeline
8/22/2025
LongBio Advances with Hong Kong IPO Amidst Promising Clinical Pipeline
8/21/2025
China Intensifies Biotech Support Amid Surge in Global Licensing Deals
8/21/2025
Novo Nordisk Meets NHC Minister to Strengthen Collaboration
8/21/2025
CStone Gains Major Backing as GIC Acquires 5.49% Stake
8/21/2025
Bio-Thera Solutions Taps STADA to Bring BAT1806 to Global Markets
8/21/2025
Henlius Biotech Expands Oncology Portfolio with Strategic Licensing Ag...
8/20/2025
Vivatides Secures Major Seed Funding to Propel Breakthrough in Oligonu...
8/19/2025
Eisai Launches First Orexin Receptor Antagonist for Insomnia in China
8/19/2025
Aeonvital Biomedical Advances Personalized Cancer Therapies with New F...
8/19/2025
RemeGen and Santen Enter into Licensing Deal for Ophthalmic Drug RC28-...
8/19/2025
CANbridge Announces Strategic Partnership and Investment from Baheal
8/18/2025
Pleryon Completes First Closing of Series A Financing
8/18/2025
Yixuan Secures Angel Financing to Advance Novel Nucleic Acid Drug Deve...
Page:
1
/
25
Total number of articles:
735
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit